ADC Therapeutics (ADCT) Other Gross PP&E Adjustments (2019 - 2023)
Historic Other Gross PP&E Adjustments for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to -$10.3 million.
- ADC Therapeutics' Other Gross PP&E Adjustments fell 5313.06% to -$10.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$10.3 million, marking a year-over-year decrease of 5313.06%. This contributed to the annual value of -$15.8 million for FY2022, which is N/A changed from last year.
- Latest data reveals that ADC Therapeutics reported Other Gross PP&E Adjustments of -$10.3 million as of Q3 2023, which was down 5313.06% from -$11.0 million recorded in Q2 2023.
- In the past 5 years, ADC Therapeutics' Other Gross PP&E Adjustments registered a high of -$3402.0 during Q3 2020, and its lowest value of -$15.8 million during Q4 2022.
- In the last 5 years, ADC Therapeutics' Other Gross PP&E Adjustments had a median value of -$7.5 million in 2021 and averaged -$7.0 million.
- As far as peak fluctuations go, ADC Therapeutics' Other Gross PP&E Adjustments crashed by 22153433.27% in 2021, and later soared by 2455.12% in 2022.
- Quarter analysis of 5 years shows ADC Therapeutics' Other Gross PP&E Adjustments stood at -$4898.0 in 2019, then surged by 30.54% to -$3402.0 in 2020, then crashed by 221534.33% to -$7.5 million in 2021, then plummeted by 109.38% to -$15.8 million in 2022, then skyrocketed by 34.93% to -$10.3 million in 2023.
- Its Other Gross PP&E Adjustments stands at -$10.3 million for Q3 2023, versus -$11.0 million for Q2 2023 and -$11.2 million for Q1 2023.